fruit on glp 1 What to Eat GLP-1: Food Guide Complete GLP-1 Diet Guide (2026)

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF

As research advances, GLP-1 RAs represent another treatment option for patients that struggle with obesity along with other comorbidities such as: hypertension and dyslipidemia

Similar results were seen in diabetic rats fed a diet rich in monounsaturated fatty acids from olive oil, where GLP-1 levels increased, weight gain decreased, and insulin sensitivity improved

Regional Segment Analysis of the GLP-1 Receptor Agonist Market North America (U.S., Canada, Mexico) Europe (Germany, France, U.K., Italy, Spain, Rest of Europe) Asia-Pacific (China, Japan, India, Rest of APAC) South America (Brazil and the Rest of South America) The Middle East and Africa (UAE, South Africa, Rest of MEA) North America influenced the market with the largest market share over the forecast period Get more details on this report - Request Free Sample PDF North America is influencing significant market growth during the forecast period due to the region's high prevalence of chronic illnesses such as diabetes and obesity, rising R&D investments for creating novel pharmaceuticals for treating diabetes and obesity, the presence of significant companies, and the well-developed healthcare infrastructure

Trials such as SURPASS-3 and SURPASS-4 compared tirzepatide to insulin therapies, demonstrating superior weight reduction and glycemic outcomes (45)